Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, H. R. Cross, Hainv Gao et al.|The Lancet Infectious Diseases|2021Cited by 338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyDavid van Duin, Robert A. Bonomo, César A. Arias et al.|The Lancet Infectious Diseases|2020Cited by 328
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is neededMark S. Butler, Peter Beyer, Valeria Gigante et al.|Archive ouverte UNIGE (University of Geneva)|2022Cited by 221
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupSarah B. Doernberg, Thomas L Holland, Thomas P. Lodise et al.|Clinical Infectious Diseases|2016Cited by 62
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Alexandra Meagan Cameron, Richard A. Alm et al.|Antimicrobial Agents and Chemotherapy|2024Cited by 25